Which funds bought or sold ABBV in Q3 2026?
Abbvie Inc. 8 funds bought, 14 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was +$2.4B.
Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)
- Wellington+$1.5B
- Bank of America+$1.3B
- Amundi+$440M
- Capital World+$386M
- Capital Research+$265M
- Holocene+$176M
- Fisher Investments+$148M
- CalPERS+$31M
- Citadel−$670M
- JPMorgan−$666M
- Goldman Sachs−$503M
- GQG−$497M
- D. E. Shaw−$395M
- Millennium−$359M
- UBS−$242M
- Northern Trust−$208M
- BalyasnyOUT−$157M
- RBC−$116M
Top 10 each side. NEW = opened a position, OUT = sold the whole position.
Bought (8)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Wellington Asset manager | Added+111.8% | +$1.5B | $2.8B |
| Bank of America Bank & broker | Added+24.2% | +$1.3B | $6.9B |
| Amundi Asset manager | Added+16.7% | +$440M | $3.1B |
| Capital World Asset manager | Added+7.7% | +$386M | $5.4B |
| Capital Research Asset manager | Added+3.4% | +$265M | $8.1B |
| Holocene Hedge fund | Added+17466.4% | +$176M | $177M |
| Fisher Investments Asset manager | Added+6% | +$148M | $2.6B |
| CalPERS Sovereign & pension | Added+3.4% | +$31M | $927M |
Sold (14)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Citadel Quant & multi-strategy | Trimmed-80.8% | −$670M | $159M |
| JPMorgan Bank & broker | Trimmed-5.3% | −$666M | $11.9B |
| Goldman Sachs Bank & broker | Trimmed-11.8% | −$503M | $3.8B |
| GQG Growth / crossover | Trimmed-98.9% | −$497M | $6M |
| D. E. Shaw Quant & multi-strategy | Trimmed-71.9% | −$395M | $155M |
| Millennium Quant & multi-strategy | Trimmed-90.5% | −$359M | $38M |
| UBS Bank & broker | Trimmed-7.2% | −$242M | $3.1B |
| Northern Trust Bank & broker | Trimmed-3.9% | −$208M | $5.2B |
| Balyasny Quant & multi-strategy | Sold out | −$157M | — |
| RBC Bank & broker | Trimmed-5.5% | −$116M | $2.0B |
| Hudson Bay Quant & multi-strategy | Trimmed-99.8% | −$105M | $249K |
| Point72 Quant & multi-strategy | Sold out | −$92M | — |
| Man Group Quant & multi-strategy | Trimmed-11.3% | −$50M | $395M |
| Glenview Hedge fund | Trimmed-16.2% | −$6M | $33M |
Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.